Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report)’s share price fell 0.9% during mid-day trading on Wednesday . The company traded as low as $3.60 and last traded at $3.61. Approximately 2,900 shares traded hands during trading, a decline of 78% from the average session volume of 13,387 shares. The stock had previously closed at $3.6440.
Medexus Pharmaceuticals Stock Up 4.5%
The company’s 50 day moving average price is $3.06 and its two-hundred day moving average price is $2.58.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
Featured Articles
- Five stocks we like better than Medexus Pharmaceuticals
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
